Vanguard Group Inc Daxor Corp Transaction History
Vanguard Group Inc
- $5.37 Trillion
- Q1 2025
A detailed history of Vanguard Group Inc transactions in Daxor Corp stock. As of the latest transaction made, Vanguard Group Inc holds 49,028 shares of DXR stock, worth $443,703. This represents 0.0% of its overall portfolio holdings.
Number of Shares
49,028
Previous 48,828
0.41%
Holding current value
$443,703
Previous $375,000
6.13%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding DXR
# of Institutions
9Shares Held
96.6KCall Options Held
0Put Options Held
0-
Jim Simons Renaissance Technologies LLC | New York, Ny28.1KShares$254,4950.0% of portfolio
-
Keyes, Stange & Wooten Wealth Management, LLC Palm Coast, FL15.9KShares$144,0210.07% of portfolio
-
Sbi Securities Co., Ltd. Tokyo, M03.13KShares$28,3080.0% of portfolio
-
Ubs Group Ag326Shares$2,9500.0% of portfolio
-
Morgan Stanley New York, NY87Shares$7870.0% of portfolio
About DAXOR CORP
- Ticker DXR
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 4,041,670
- Market Cap $36.6M
- Description
- Daxor Corporation, a medical device company, provides blood volume measurement technology focused on blood volume testing. The company develops and markets BVA-100 Blood Volume Analyzer, a diagnostic blood test to provide safe, accurate, objective quantification of blood volume status and composition compared to patient-specific norms for used i...